T1	PROC 7 45	Optimización de la Terapia Antibiótica
T2	CHEM 70 97	Antibióticos betalactámicos
#1	AnnotatorNotes T2	C0026458; Monobactams; Organic Chemical · Antibiotic
T3	PROC 101 119	perfusión continua
#2	AnnotatorNotes T3	C0444889; Continuous infusion; Therapeutic or Preventive Procedure
T4	PROC 987 1002	fórmula CKD-EPI
#3	AnnotatorNotes T4	C2964649; Creatinine-based formula (CKD-EPI); Laboratory Procedure
T5	CHEM 217 240	piperacilina/tazobactam
#4	AnnotatorNotes T5	C0250480; piperacillin-tazobactam combination; Pharmacologic Substance
T6	CHEM 243 252	meropenem
#5	AnnotatorNotes T6	C0066005; meropenem; Organic Chemical · Antibiotic
T7	PROC 256 274	perfusión continua
#6	AnnotatorNotes T7	C0444889; Continuous infusion; Therapeutic or Preventive Procedure
T8	PROC 1027 1035	tratados
#7	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T9	PROC 1253 1264	UHPLC-MS/MS
#8	AnnotatorNotes T9	C4053724; Ultra High-performance Liquid Chromatography/Tandem Mass Spectrometry; Laboratory Procedure
T10	PROC 487 519	concentración mínima inhibitoria
#9	AnnotatorNotes T10	C0427978; Minimum Inhibitory Concentration measurement; Laboratory Procedure
T11	PROC 535 538	CMI
#10	AnnotatorNotes T11	C0427978; Minimum Inhibitory Concentration measurement; Laboratory Procedure
T12	PROC 586 613	estudio clínico prospectivo
#11	AnnotatorNotes T12	C0033522; Prospective Studies; Research Activity
T13	CHEM 34 45	Antibiótica
#12	AnnotatorNotes T13	C0003232; Antibiotics; Antibiotic
T14	CHEM 683 710	antibióticos betalactámicos
#13	AnnotatorNotes T14	C0026458; Monobactams; Organic Chemical · Antibiotic
T15	PROC 728 746	perfusión continua
#14	AnnotatorNotes T15	C0444889; Continuous infusion; Therapeutic or Preventive Procedure
T16	PROC 1979 1987	tratados
#15	AnnotatorNotes T16	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T17	PROC 958 977	filtrado glomerular
#16	AnnotatorNotes T17	C0017654; Glomerular Filtration Rate; Diagnostic procedure
T18	PROC 2720 2723	MIC
#17	AnnotatorNotes T18	C0427978; Minimum Inhibitory Concentration measurement; Laboratory Procedure
T19	CHEM 1058 1085	antibióticos betalactámicos
#18	AnnotatorNotes T19	C0026458; Monobactams; Organic Chemical · Antibiotic
T20	PROC 1089 1107	perfusión continua
#19	AnnotatorNotes T20	C0444889; Continuous infusion; Therapeutic or Preventive Procedure
T21	PROC 1195 1251	cromatografía líquida acoplada a espectrometría de masas
#20	AnnotatorNotes T21	C4053724; Ultra High-performance Liquid Chromatography/Tandem Mass Spectrometry; Laboratory Procedure
T23	PROC 618 675	analiza el comportamiento farmacocinético/farmacodinámico
#22	AnnotatorNotes T23	C0201734; Pharmacokinetic study; Research Activity + C1709518; Pharmacodynamic Study; Research Activity
T24	PROC 1292 1324	concentración mínima inhibitoria
#23	AnnotatorNotes T24	C0427978; Minimum Inhibitory Concentration measurement; Laboratory Procedure
T25	CHEM 1372 1396	piperacilina/ tazobactam
#24	AnnotatorNotes T25	C0250480; piperacillin-tazobactam combination; Pharmacologic Substance
T26	CHEM 1468 1477	meropenem
#25	AnnotatorNotes T26	C0066005; meropenem; Organic Chemical · Antibiotic
T27	PROC 1610 1646	concentraciones mínimas inhibitorias
#26	AnnotatorNotes T27	C0427978; Minimum Inhibitory Concentration measurement; Laboratory Procedure
T28	CHEM 1701 1710	meropenem
#27	AnnotatorNotes T28	C0066005; meropenem; Organic Chemical · Antibiotic
T29	CHEM 1716 1739	piperacilina/tazobactam
#28	AnnotatorNotes T29	C0250480; piperacillin-tazobactam combination; Pharmacologic Substance
T30	PROC 1778 1797	filtrado glomerular
#29	AnnotatorNotes T30	C0017654; Glomerular Filtration Rate; Diagnostic procedure
T31	CHEM 1913 1922	meropenem
#30	AnnotatorNotes T31	C0066005; meropenem; Organic Chemical · Antibiotic
T32	CHEM 1941 1953	piperacilina
#31	AnnotatorNotes T32	C0031955; piperacillin; Organic Chemical · Antibiotic
T33	CHEM 1992 2001	meropenem
#32	AnnotatorNotes T33	C0066005; meropenem; Organic Chemical · Antibiotic
T34	CHEM 2128 2151	piperacilina/tazobactam
#33	AnnotatorNotes T34	C0250480; piperacillin-tazobactam combination; Pharmacologic Substance
T35	DISO 2473 2504	infecciones por microorganismos
T36	PROC 2509 2545	concentraciones mínimas inhibitorias
#34	AnnotatorNotes T36	C0427978; Minimum Inhibitory Concentration measurement; Laboratory Procedure
T37	CHEM 2638 2647	meropenem
#35	AnnotatorNotes T37	C0066005; meropenem; Organic Chemical · Antibiotic
T38	PROC 2651 2669	perfusión continua
#36	AnnotatorNotes T38	C0444889; Continuous infusion; Therapeutic or Preventive Procedure
T39	CHEM 2773 2796	piperacilina/tazobactam
#37	AnnotatorNotes T39	C0250480; piperacillin-tazobactam combination; Pharmacologic Substance
T40	PROC 2919 2949	monitorización farmacocinética
#38	AnnotatorNotes T40	C0201734; Pharmacokinetic study; Research Activity
T41	PROC 2984 3008	optimización terapéutica
T42	PROC 378 392	administración
#39	AnnotatorNotes T42	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T43	CHEM 423 434	antibiótico
#40	AnnotatorNotes T43	C0003232; Antibiotics; Antibiotic
T44	ANAT 942 947	renal
#41	AnnotatorNotes T44	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T45	CHEM 2423 2435	antibióticos
#42	AnnotatorNotes T45	C0003232; Antibiotics; Antibiotic
T46	CHEM 2862 2874	antibióticos
#43	AnnotatorNotes T46	C0003232; Antibiotics; Antibiotic
T47	LIVB 52 68	paciente Crítico
#44	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group + C0815272; critical population; Population Group
T48	Route 101 110	perfusión
#45	AnnotatorNotes T48	C1621368; Intravenous Drip Route of Administration; Functional Concept
T49	LIVB 160 169	pacientes
#46	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	Route 256 265	perfusión
#47	AnnotatorNotes T50	C1621368; Intravenous Drip Route of Administration; Functional Concept
T51	Route 728 737	perfusión
#48	AnnotatorNotes T51	C1621368; Intravenous Drip Route of Administration; Functional Concept
T52	LIVB 750 768	pacientes críticos
#49	AnnotatorNotes T52	C0815272; critical population; Population Group
T53	Date 868 881	junio de 2015
T54	Date 884 896	mayo de 2017
T55	LIVB 922 929	adultos
#50	AnnotatorNotes T55	C0001675; Adult; Age Group
T57	Route 1089 1098	perfusión
#51	AnnotatorNotes T57	C1621368; Intravenous Drip Route of Administration; Functional Concept
T59	LIVB 1339 1354	microorganismos
#52	AnnotatorNotes T59	C0445623; Microorganism; Organism
T60	Dose 1398 1405	16 mg/l
T61	LIVB 1411 1433	Pseudomonas aeruginosa
#53	AnnotatorNotes T61	C0033809; Pseudomonas aeruginosa; Bacterium
T62	Dose 1436 1442	8 mg/l
T63	LIVB 1448 1466	Enterobacteriaceae
#54	AnnotatorNotes T63	C0014346; Enterobacteriaceae; Bacterium
T64	Dose 1479 1485	2 mg/l
T65	LIVB 1510 1524	microorganismo
#55	AnnotatorNotes T65	C0445623; Microorganism; Organism
T66	LIVB 1568 1577	pacientes
#56	AnnotatorNotes T66	C0030705; Patients; Patient or Disabled Group
T67	LIVB 1687 1696	pacientes
#57	AnnotatorNotes T67	C0030705; Patients; Patient or Disabled Group
T68	Age 1753 1760	59 años
T71	Dose 1897 1912	16 mg/l (11-29)
T72	Dose 1925 1940	40 mg/l (21-51)
T73	LIVB 1969 1978	pacientes
#58	AnnotatorNotes T73	C0030705; Patients; Patient or Disabled Group
T75	LIVB 2080 2098	Enterobacteriaceae
#59	AnnotatorNotes T75	C0014346; Enterobacteriaceae; Bacterium
T76	LIVB 2101 2112	Pseudomonas
#60	AnnotatorNotes T76	C0033808; Pseudomonas; Bacterium
T77	LIVB 2176 2185	pacientes
#61	AnnotatorNotes T77	C0030705; Patients; Patient or Disabled Group
T78	LIVB 2220 2238	Enterobacteriaceae
#62	AnnotatorNotes T78	C0014346; Enterobacteriaceae; Bacterium
T79	LIVB 2241 2252	Pseudomonas
#63	AnnotatorNotes T79	C0033808; Pseudomonas; Bacterium
T80	LIVB 2258 2272	microorganismo
#64	AnnotatorNotes T80	C0445623; Microorganism; Organism
T81	Spec_cue 2273 2283	sospechoso
T82	LIVB 2306 2315	pacientes
#65	AnnotatorNotes T82	C0030705; Patients; Patient or Disabled Group
T84	Spec_cue 2461 2472	sospecha de
T85	LIVB 2489 2504	microorganismos
#66	AnnotatorNotes T85	C0445623; Microorganism; Organism
T86	LIVB 2556 2578	Pseudomonas aeruginosa
#67	AnnotatorNotes T86	C0033809; Pseudomonas aeruginosa; Bacterium
T87	LIVB 2581 2596	enterobacterias
#68	AnnotatorNotes T87	C0014346; Enterobacteriaceae; Bacterium
T88	Dose 2614 2634	dosis convencionales
T89	Route 2651 2660	perfusión
#69	AnnotatorNotes T89	C1621368; Intravenous Drip Route of Administration; Functional Concept
T90	PHYS 2934 2949	farmacocinética
#70	AnnotatorNotes T90	C0031327; Drug Kinetics; Physiologic Function
T91	Dose 199 213	dosis estándar
T92	PHYS 934 947	función renal
#71	AnnotatorNotes T92	C0232804; Renal function; Organ or Tissue Function
T93	Dose 1040 1054	dosis estándar
T58	Dose 2753 2769	dosis superiores
T70	Dose 2838 2852	dosis estándar
T74	PHYS 629 659	comportamiento farmacocinético
#72	AnnotatorNotes T74	C0031327; Drug Kinetics; Physiologic Function
T83	PHYS 301 316	farmacocinético
#73	AnnotatorNotes T83	C0031327; Drug Kinetics; Physiologic Function
T94	PHYS 2025 2040	farmacocinético
#74	AnnotatorNotes T94	C0031327; Drug Kinetics; Physiologic Function
T56	PHYS 317 332	farmacodinámico
#75	AnnotatorNotes T56	C0851347; Pharmacodynamics; Biologic Function
T69	PHYS 660 675	farmacodinámico
#76	AnnotatorNotes T69	C0851347; Pharmacodynamics; Biologic Function
T95	PHYS 2041 2056	farmacodinámico
#77	AnnotatorNotes T95	C0851347; Pharmacodynamics; Biologic Function
T96	ANAT 967 977	glomerular
#78	AnnotatorNotes T96	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
T97	ANAT 1787 1797	glomerular
#79	AnnotatorNotes T97	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
A1	Assertion T78 Speculated
A2	Assertion T79 Speculated
A3	Assertion T35 Speculated
A4	Population_data T55 Age
R1	Used_for Arg1:T13 Arg2:T1	
R2	Experiences Arg1:T47 Arg2:T13	
R3	Experiences Arg1:T47 Arg2:T2	
R4	Used_for Arg1:T2 Arg2:T3	
R5	Has_Route_or_Mode Arg1:T2 Arg2:T48	
R6	Experiences Arg1:T49 Arg2:T5	
R7	Experiences Arg1:T49 Arg2:T6	
R8	Has_Route_or_Mode Arg1:T5 Arg2:T50	
R9	Has_Route_or_Mode Arg1:T6 Arg2:T50	
R10	Used_for Arg1:T5 Arg2:T7	
R11	Used_for Arg1:T6 Arg2:T7	
R12	Has_Dose_or_Strength Arg1:T5 Arg2:T91	
R13	Has_Dose_or_Strength Arg1:T6 Arg2:T91	
R14	Experiences Arg1:T49 Arg2:T83	
R15	Experiences Arg1:T49 Arg2:T56	
T98	CONC 294 332	índice farmacocinético/farmacodinámico
R16	Experiences Arg1:T49 Arg2:T42	
R17	Used_for Arg1:T43 Arg2:T42	
T99	Dose 404 419;448 519	concentraciones cuatro veces iguales o superiores a la concentración mínima inhibitoria
T100	Quantifier_or_Qualifier 435 440	libre
R18	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T100	
R19	Has_Dose_or_Strength Arg1:T43 Arg2:T99	
T101	Dose 529 538	≥ 4 x CMI
R20	Has_Dose_or_Strength Arg1:T43 Arg2:T101	
R21	Used_for Arg1:T14 Arg2:T15	
R22	Has_Route_or_Mode Arg1:T14 Arg2:T51	
R23	Experiences Arg1:T52 Arg2:T14	
R24	Experiences Arg1:T52 Arg2:T74	
R25	Experiences Arg1:T52 Arg2:T69	
R26	Experiences Arg1:T55 Arg2:T92	
R27	Location_of Arg1:T44 Arg2:T92	
T102	Observation 934 956	función renal correcta
R29	Location_of Arg1:T96 Arg2:T17	
T103	Result_or_Value 1003 1023	≥ 60 ml/min/1,73 m 2
R30	Has_Result_or_Value Arg1:T17 Arg2:T103	
R31	Used_for Arg1:T19 Arg2:T8	
R32	Experiences Arg1:T55 Arg2:T17	
R34	Experiences Arg1:T55 Arg2:T8	
R35	Has_Dose_or_Strength Arg1:T19 Arg2:T93	
R36	Has_Route_or_Mode Arg1:T19 Arg2:T57	
R37	Used_for Arg1:T19 Arg2:T20	
R38	Experiences Arg1:T55 Arg2:T20	
T104	Observation 1359 1370	resistentes
R40	Has_Quantifier_or_Qualifier Arg1:T59 Arg2:T104	
R41	Has_Dose_or_Strength Arg1:T25 Arg2:T60	
R42	Has_Dose_or_Strength Arg1:T26 Arg2:T64	
R43	Has_Dose_or_Strength Arg1:T25 Arg2:T62	
T105	Quantifier_or_Qualifier 1647 1653	reales
R44	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T105	
R45	Experiences Arg1:T66 Arg2:T27	
T106	Observation 1582 1608	aislamiento microbiológico
R46	Experiences Arg1:T66 Arg2:T106	
R47	Experiences Arg1:T67 Arg2:T28	
R48	Experiences Arg1:T67 Arg2:T29	
R49	Location_of Arg1:T97 Arg2:T30	
T107	CONC 1113 1165	concentraciones en estado de equilibrio estacionario
#80	AnnotatorNotes T107	C0678757; drug steady state concentration; Quantitative Concept
T108	CONC 1837 1889	concentraciones en estado de equilibrio estacionario
#81	AnnotatorNotes T108	C0678757; drug steady state concentration; Quantitative Concept
T109	Quantifier_or_Qualifier 1890 1895	libre
R50	Has_Quantifier_or_Qualifier Arg1:T108 Arg2:T109	
R51	Has_Dose_or_Strength Arg1:T31 Arg2:T71	
R52	Has_Dose_or_Strength Arg1:T32 Arg2:T72	
R53	Experiences Arg1:T73 Arg2:T16	
R54	Used_for Arg1:T33 Arg2:T16	
R55	Experiences Arg1:T73 Arg2:T94	
R56	Experiences Arg1:T73 Arg2:T95	
T110	Neg_cue 2058 2061	sin
T111	CONC 2062 2073	diferencias
A5	Assertion T111 Negated
#82	AnnotatorNotes T111	C1705241; Delta (difference); Quantitative Concept
R57	Negation Arg1:T110 Arg2:T111	
R58	Experiences Arg1:T77 Arg2:T34	
R59	Speculation Arg1:T81 Arg2:T78	
R60	Speculation Arg1:T81 Arg2:T79	
T112	Observation 2328 2354	aislamiento microbiológico
R61	Experiences Arg1:T82 Arg2:T112	
T113	Neg_cue 2393 2396	sin
T114	CONC 2397 2408	diferencias
A6	Assertion T114 Negated
R62	Negation Arg1:T113 Arg2:T114	
#83	AnnotatorNotes T114	C1705241; Delta (difference); Quantitative Concept
R63	Speculation Arg1:T84 Arg2:T35	
R64	Causes Arg1:T85 Arg2:T35	
T115	Result_or_Value 2546 2554	elevadas
R65	Has_Result_or_Value Arg1:T36 Arg2:T115	
R66	Causes Arg1:T86 Arg2:T35	
R67	Causes Arg1:T87 Arg2:T35	
R68	Has_Dose_or_Strength Arg1:T37 Arg2:T88	
R69	Has_Route_or_Mode Arg1:T37 Arg2:T89	
R70	Used_for Arg1:T37 Arg2:T38	
T116	Dose 2714 2723	≥ 4 x MIC
R71	Has_Dose_or_Strength Arg1:T37 Arg2:T116	
R72	Overlap Arg1:T35 Arg2:T37	
R73	Has_Dose_or_Strength Arg1:T39 Arg2:T58	
T117	Observation 2810 2836	aislamiento microbiológico
R74	Has_Dose_or_Strength Arg1:T46 Arg2:T70	
T118	Quantifier_or_Qualifier 333 338	diana
#84	AnnotatorNotes T118	C1521840; Target; Functional Concept
T119	CONC 2200 2205	diana
#85	AnnotatorNotes T119	C1521840; Target; Functional Concept
T120	CONC 2386 2391	diana
#86	AnnotatorNotes T120	C1521840; Target; Functional Concept
T121	CONC 2909 2914	diana
#87	AnnotatorNotes T121	C1521840; Target; Functional Concept
T122	CONC 2701 2706	diana
#88	AnnotatorNotes T122	C1521840; Target; Functional Concept
T22	Quantifier_or_Qualifier 1325 1333	teóricos
R39	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T22	
T123	Quantifier_or_Qualifier 1355 1358	más
#21	AnnotatorNotes T104	C3542449; Drug Resistance Status; Finding
R77	Has_Quantifier_or_Qualifier Arg1:T104 Arg2:T123	
T124	Spec_cue 2738 2752	se requerirían
R78	Speculation Arg1:T124 Arg2:T58	
A7	Assertion T58 Speculated
A8	Assertion T39 Speculated
R79	Speculation Arg1:T124 Arg2:T39	
R33	Has_Quantifier_or_Qualifier Arg1:T98 Arg2:T118	
#89	AnnotatorNotes T100	C0332296; Free of (attribute); Functional Concept
#90	AnnotatorNotes T102	C0232805; Normal renal function; Finding
R28	Experiences Arg1:T55 Arg2:T102	
R80	Location_of Arg1:T44 Arg2:T102	
#91	AnnotatorNotes T109	C0332296; Free of (attribute); Functional Concept
#92	AnnotatorNotes T115	C3163633; Elevated; Qualitative Concept
#93	AnnotatorNotes T35	C0009450; Communicable Diseases; Disease or Syndrome
#94	AnnotatorNotes T123	C0205172; More; Quantitative Concept
#95	AnnotatorNotes T41	C4075704; Optimization of medication; Therapeutic or Preventive Procedure
#96	AnnotatorNotes T105	C0237400; Actual; Qualitative Concept
A9	Experiencer T47 Patient
A10	Experiencer T49 Patient
A11	Experiencer T52 Patient
A12	Experiencer T55 Patient
A13	Experiencer T66 Patient
A14	Experiencer T67 Patient
A15	Experiencer T73 Patient
A16	Experiencer T77 Patient
A17	Experiencer T82 Patient
